Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
about
Medical methods for mid-trimester termination of pregnancyCloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT)Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinitiesContraceptive use of antiprogestin.Incidence and predictors of maternal cardiovascular mortality and severe morbidity in The Netherlands: a prospective cohort studyDifferential reactivity of human mammary artery and saphenous vein to prostaglandin E(2) : implication for cardiovascular grafts.Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.Termination of pregnancy with mifepristone.Sulprostone for pregnancy termination in women with severe (pre-) eclampsia.Complete recovery after 2 h of cardiopulmonary resuscitation following high-dose prostaglandin treatment for atonic uterine haemorrhage.Cardiac arrest during sulprostone administration--a case report.Emotional impact and acceptability of medical abortion with mifepristone: a German experience.Development of medical termination of pregnancy: a review.Effects of a prolonged, 72 hours, interval between mifepristone and gemeprost in second trimester termination of pregnancy: a retrospective analysis.A prospective open-label study of home use of mifepristone for medical abortion in Nepal.
P2860
Q24234827-BFC6D926-778C-4499-9A5A-CC220CD932E8Q24319949-1DDCF21D-09E1-4B9E-B06E-B23B607B310DQ28594671-891BC04A-4CF5-4827-9845-C7887CA8FFC5Q33700142-8B7BA0E1-8916-4177-BED7-E87D2CDAA00FQ34606863-E91443E4-5A4E-4283-AF47-3E90B59FEDC9Q35036193-894060A2-E185-4C88-9341-2A3E6E042EBEQ35189414-5113D873-DBCA-47E0-9197-B242DB4D623DQ43151448-7361DB71-6CD2-4E6C-BF42-A4B3898288BFQ44099907-64C93D24-2953-431D-BB3D-B39650FFA8DFQ44169430-D3910260-25A9-4900-B016-82B51B11F75CQ44507516-59A934B5-E891-45D5-B63E-C8AA1DE55D07Q48484559-75769649-C062-43C0-80E7-60FDA2C638ABQ50253360-D9ADF123-D81F-468C-9B64-9FD807B7DF7AQ53532224-C08D4BC3-7E91-4BF5-A40B-39D6F4A75FC7Q53668812-668854BD-F19E-405D-8FFE-3BD78F267ED1
P2860
Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Medical termination of early p ...... alogue. Study in 16,369 women.
@ast
Medical termination of early p ...... alogue. Study in 16,369 women.
@en
Medical termination of early p ...... alogue. Study in 16,369 women.
@nl
type
label
Medical termination of early p ...... alogue. Study in 16,369 women.
@ast
Medical termination of early p ...... alogue. Study in 16,369 women.
@en
Medical termination of early p ...... alogue. Study in 16,369 women.
@nl
prefLabel
Medical termination of early p ...... alogue. Study in 16,369 women.
@ast
Medical termination of early p ...... alogue. Study in 16,369 women.
@en
Medical termination of early p ...... alogue. Study in 16,369 women.
@nl
P2093
P1476
Medical termination of early p ...... alogue. Study in 16,369 women.
@en
P2093
C J Aguillaume
E E Baulieu
L Silvestre
P304
P356
10.3109/00016349209021052
P577
1992-05-01T00:00:00Z